We use cookies to customise content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. For further information, please read our cookie policy.
Maus, V., Weber, W., Berlis, A., Maurer, C., & Fischer, S.
Initial Experience with Surpass Evolve Flow Diverter in the Treatment of Intracranial Aneurysms
86%
Favorable occlusion rate (OKM C-D) at 4 months
75%
Complete occlusion rate (OKM D) at 4 months
| Number of patients | 42 |
| Number of aneurysms | 46 |
| Major morbidity and mortality | 2% |
| In-stent stenosis (≥50%) | 3% (1/34) |
Clinical Neuroradiology | 2020
Maus, V., Weber, W., Berlis, A., Maurer, C., & Fischer, S. (2021). Initial Experience with Surpass Evolve Flow Diverter in the Treatment of Intracranial Aneurysms. Clinical neuroradiology, 31(3), 681–689. https://doi.org/10.1007/s00062-020-00972-5
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004698 v1.0